von Willebrand Diseases
Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.
Subtype terms (3)
More specific conditions that are subtypes of von Willebrand Diseases in the MeSH hierarchy.
- von Willebrand Disease, Type 1
1 drug approved
- von Willebrand Disease, Type 2
1 drug experimental
- von Willebrand Disease, Type 3
3 drugs approved
Drugs by status
Approved for this indication (3)
Phase 4 trials (1)
Phase 3 trials (3)
Phase 2 trials (4)
Phase 1 trials (2)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (5)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (3)